WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.

更新时间：2025-07-11 直链：westvacpharma.com

更新时间：2025-07-11 直链：xcarbon.cc

Bearingtheaimofcarbonneutralityinmind,we,HefeiSinopowerTechnologiesCo.Ltd.

更新时间：2025-07-10 直链：hfch.cn

ISC·EREDA成立1988年，伊罗达自2011年全面展开中国事业以来，不断探索工业环境与能源可持续发展奥秘，基于对全球未来30年实现碳中和承诺，我们一直致力于工业与能源温控的研究，为全球提供热管理产品及解决方案。 ISC·EREDAwasfoundedin1988.SincefullylaunchingitsbusinessinChinain2011,EREDAhascontinuouslyexploredthemysteriesofsustainabledevelopmentinindustrialenvironmentandenergy.Basedonourcommitmenttoachievingcarbonneutralityinthenext30yearsglobally,wehavebeencommittedtoresearchonindustrialandenergytemperaturecontrol,providingheatingmanageme

更新时间：2025-07-10 直链：www.ereda.cn

更新时间：2025-06-26 直链：neutral.vclusters.com

CorporationCarbonNeutralAction（CCNA）企业间碳中和对话与协作平台

更新时间：2025-06-24 直链：www.cncarbonneutral.cn

ShowcaseSupplier,CommercialRefrigerator,NeutralStainlessSteelManufacturers/Suppliers-Yichu(Qingdao)KitchenEquipmentCo.,Ltd

更新时间：2025-06-24 直链：gdasian.en.made-in-china.com

BJJSHYfocusesonprovidingUAVsystemandaviationinformationservicesystemsolutionsandcarbonneutralecologicalmonitoringproducts.

更新时间：2025-06-23 直链：bjjshy.com.cn